Prognostic Value of INR Fluctuations during Anticoagulant Therapy in Patients with Atrial Fibrillation and a High Thromboembolic Risk

Publisher： Karger

E-ISSN： 1424-0556|4|2|80-86

ISSN： 1422-9528

Source： Heart Drug, Vol.4, Iss.2, 2004-05, pp. : 80-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events

By Yinon Yoav   Pauzner Rachel   Dulitzky Mordechai   Elizur Shai E   Dor Jehoshua   Shulman Adrian  

Reproductive BioMedicine Online, Vol. 12, Iss. 3, 2006-03 ,pp. : 354-358

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3816-3826

Bentham Science Publishers

Access to resources Recommend Favorite

Updates in Antiarrhythmic Therapy for Atrial Fibrillation in Geriatric Patients

By  

The Consultant Pharmacist, Vol. 30, Iss. 2, 2015-02 ,pp. : 82-91

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Aim for INR 2 in nonvalvular atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1405, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Risk of atrial fibrillation with high-dose corticosteroids

By Chiappini Bruno   El Khoury Gebrine  

Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. : 811-814

Informa Healthcare

Access to resources Recommend Favorite